CG
DGX icon

Cutler Group’s Quest Diagnostics DGX Stock Holding History

Cutler Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,298
Closed -$203K – 3964
2022
Q4 		$203K Buy
1,298
+800
+161% +$115K 0.02% 777
2022
Q3 		$61K Sell
498
-400
-45% -$52.7K ﹤0.01% 1756
2022
Q2 		$119K Buy
+898
New +$122K 0.01% 1326
2018
Q1 		– Sell
-1,493
Closed -$153K – 4599
2017
Q4 		$147K Sell
1,493
-4,256
-74% -$403K 0.01% 1144
2017
Q3 		$538K Buy
5,749
+5,671
+7,271% +$602K 0.02% 622
2017
Q2 		$8K Sell
78
-20
-20% -$2.12K ﹤0.01% 4351
2017
Q1 		$9K Sell
98
-200
-67% -$19.1K ﹤0.01% 4133
2016
Q4 		$27K Sell
298
-1,940
-87% -$167K ﹤0.01% 3151
2016
Q3 		$189K Buy
+2,238
New +$188K 0.01% 1269
2016
Q2 		– Sell
-4,785
Closed -$364K – 6745
2016
Q1 		$341K Buy
4,785
+3,409
+248% +$229K 0.02% 704
2015
Q4 		$97K Buy
+1,376
New +$92.5K 0.01% 1789

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cutler Group's DGX Position: Q1 2023 in Review

Cutler Group sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 1,298 shares — an estimated $203K sold.

Cutler Group first reported a position in DGX in Q4 2015 and held it in 11 quarters. The position peaked at $538K in Q3 2017. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • Cutler Group reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 1,298 Quest Diagnostics shares in Q1 2023, an estimated $203K.
  • Cutler Group first reported a position in Quest Diagnostics in Q4 2015 and held it in 11 quarters.
  • Cutler Group's Quest Diagnostics position peaked at $538K in Q3 2017.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.